PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
Tanggal 31 Desember 2019 OF FINANCIAL POSITION
(Disajikan dalam Rupiah, kecuali dinyatakan lain) As of December 31, 2019
(Expressed in Rupiah, unless otherwise stated)
ASET ASSETS
ASET LANCAR CURRENT ASSETS
Kas dan setara kas 3.040.487.103.572 2e,2s,2v,4,39 3.153.327.557.478 Cash and cash equivalents
Piutang usaha 2s,2v,5,39 Trade receivables
Pihak ketiga, neto 3.531.177.696.227 3.230.855.504.419 Third parties, net
Pihak berelasi 41.677.083.452 2f,8a 24.689.355.369 Related parties
Piutang lain-lain 2s,2v,6,39 Other receivables
Pihak ketiga 122.554.254.390 116.632.910.355 Third parties
Pihak berelasi 2.251.088.014 2f,8b 1.391.500.261 Related parties
Aset keuangan lancar lainnya 195.618.535.562 2e,2s,2v,7,39 178.719.216.214 Other current financial assets
Persediaan, neto 3.737.976.007.703 2g,9 3.474.587.231.854 Inventories, net
Pajak pertambahan nilai
dibayar di muka 147.588.077.744 2u 123.737.714.663 Prepaid value added tax
Biaya dibayar di muka 85.488.759.946 2h,10 62.218.079.760 Prepaid expenses
Aset lancar lainnya 317.672.371.791 11 282.129.316.353 Other current assets
Catatan atas laporan keuangan konsolidasian terlampir The accompanying notes to the consolidated financial
merupakan bagian integral dari laporan keuangan statement form an integral part of these consolidated financial
konsolidasian. statements.
1
The original consolidated financial statements included herein are in
the Indonesian language.
PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
(lanjutan) OF FINANCIAL POSITION (continued)
Tanggal 31 Desember 2019 As of December 31, 2019
(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
LIABILITAS LIABILITIES
Catatan atas laporan keuangan konsolidasian terlampir The accompanying notes to the consolidated financial
merupakan bagian integral dari laporan statements form an integral part of these consolidated
keuangan konsolidasian. financial statements.
2
The original consolidated financial statements included herein are in
the Indonesian language.
PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
(lanjutan) OF FINANCIAL POSITION (continued)
Tanggal 31 Desember 2019 As of December 31, 2019
(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
EKUITAS EQUITY
Ekuitas yang Dapat
Diatribusikan kepada Equity Attributable to the
Pemilik Entitas Induk Owners of the Parent Company
Modal saham - nilai nominal Share capital - Rp10 par value
Rp10 per saham per share
Modal dasar - Authorized -
85.000.000.000 saham 85,000,000,000 shares
Modal ditempatkan dan disetor Issued and fully paid -
penuh - 46.875.122.110 saham 468.751.221.100 2y,22 468.751.221.100 46,875,122,110 shares
Tambahan modal disetor, neto (34.118.673.814) 2d,2y,23 (34.118.673.814) Additional paid-in capital, net
Differences arising from
Selisih transaksi dengan transaction with
kepentingan non-pengendali 52.932.836.056 2c,24 46.967.626.117 non-controlling interests
Saldo laba 2z Retained earnings
Telah ditentukan penggunaannya 225.961.420.648 22 201.390.130.325 Appropriated
Belum ditentukan penggunaannya 15.135.159.090.134 13.871.718.983.242 Unappropriated
Penghasilan komprehensif lain 2aa Other comprehensive income
Selisih kurs atas penjabaran Differences arising from foreign
laporan keuangan 57.824.661.761 2c 71.460.322.752 currency translation
Laba belum direalisasi Unrealized gain on
dari aset keuangan tersedia available-for-sale
untuk dijual, neto 56.006.158.259 2v,7,12 42.056.395.763 financial assets, net
Kerugian aktuarial atas Actuarial loss on
liabilitas imbalan kerja long-term employee
jangka panjang, neto (69.390.323.150) 2t (44.768.029.424) benefits liability, net
Catatan atas laporan keuangan konsolidasian terlampir The accompanying notes to the consolidated financial
merupakan bagian integral dari laporan statements form an integral part of these consolidated
keuangan konsolidasian. financial statements.
3
The original consolidated financial statements included herein are in
the Indonesian language.
PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN LABA RUGI DAN PENGHASILAN CONSOLIDATED STATEMENT OF PROFIT OR LOSS
KOMPREHENSIF LAIN KONSOLIDASIAN AND OTHER COMPREHENSIVE INCOME
Untuk Tahun yang Berakhir pada Tanggal For the Year Ended December 31, 2019
31 Desember 2019 (Expressed in Rupiah, unless otherwise stated)
(Disajikan dalam Rupiah, kecuali dinyatakan lain)
Catatan/
2019 Notes 2018
2f,2r,2w,8c
PENJUALAN NETO 22.633.476.361.038 26,27 21.074.306.186.027 NET SALES
2f,2r,2w,8f,
BEBAN POKOK PENJUALAN (12.390.008.590.196) 26,28 (11.226.380.392.484) COST OF GOODS SOLD
BEBAN PAJAK PENGHASILAN, Neto (865.015.000.888) 2u,2w,21,26 (809.137.704.264) INCOME TAX EXPENSE, Net
Catatan atas laporan keuangan konsolidasian terlampir The accompanying notes to the consolidated financial
merupakan bagian integral dari laporan statements form an integral part of these consolidated
keuangan konsolidasian. financial statements.
4
The original consolidated financial statements included herein are in
the Indonesian language.
PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN LABA RUGI DAN PENGHASILAN CONSOLIDATED STATEMENT OF PROFIT OR LOSS
KOMPREHENSIF LAIN KONSOLIDASIAN (lanjutan) AND OTHER COMPREHENSIVE INCOME
Untuk Tahun yang Berakhir pada Tanggal (continued)
31 Desember 2019 For the Year Ended December 31, 2019
(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
Catatan/
2019 Notes 2018
Catatan atas laporan keuangan konsolidasian terlampir The accompanying notes to the consolidated financial
merupakan bagian integral dari laporan statements form an integral part of these consolidated
keuangan konsolidasian. financial statements.
5
The original consolidated financial statements included herein are in the Indonesian language.
PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN PERUBAHAN EKUITAS KONSOLIDASIAN CONSOLIDATED STATEMENT OF
Untuk Tahun yang Berakhir pada Tanggal CHANGES IN EQUITY
31 Desember 2019 For the Year Ended December 31, 2019
(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
Ekuitas yang Dapat Diatribusikan kepada Pemilik Entitas Induk/Equity Attributable to the Owners of the Parent Company
Selisih Kurs
Selisih atas Kerugian
Transaksi Penjabaran Laba Belum Aktuarial atas
dengan Kepentingan Laporan Direalisasi dari Liabilitas Imbalan
Modal Non-pengendali/ Saldo Laba/ Keuangan/ Aset Keuangan Kerja Jangka
Ditempatkan dan Differences Retained Earnings Differences Tersedia untuk Panjang, Neto/
Disetor Penuh/ Tambahan Arising from Arising from Dijual, Neto/ Actuarial Loss on Kepentingan
Issued and Modal Disetor, Neto/ Transaction with Telah Ditentukan Belum Ditentukan Foreign Unrealized Gains on for Long-term Non-pengendali/
Catatan/ Fully Paid Additional Non-controlling Penggunaannya/ Penggunaannya/ Currency Available-for-Sale Employee Benefits Sub-total/ Non-controlling Total Ekuitas/
Notes Capital Paid-in Capital, Net Interests Appropriated Unappropriated Translation Financial Assets, Net Liability, Net Sub-total Interests Total Equity
Saldo pada tanggal 31 Desember 2017 468.751.221.100 (34.118.673.814) 42.779.769.837 177.354.070.991 12.610.504.063.055 60.871.490.099 36.878.429.914 (82.212.896.444 ) 13.280.807.474.738 613.224.307.951 13.894.031.782.689 Balance as of December 31, 2017
Saldo laba yang telah ditentukan penggunaannya untuk cadangan umum 2z,22 - - - 24.036.059.334 (24.036.059.334) - - - - - - Appropriation of retained earnings for general reserves
Selisih kurs atas penjabaran laporan keuangan 2c - - - - - - - - - 66.515.350 66.515.350 Differences arising from foreign currency translation
Pencairan aset keuangan tersedia untuk dijual 2v,7 - - - - - - (310.181.459) - (310.181.459) - (310.181.459) Withdrawal of available-for-sale financial assets
Setoran modal dari kepentingan non-pengendali entitas anak 2c,24 - - 4.187.856.280 - - - - - 4.187.856.280 34.529.143.720 38.717.000.000 Additional capital from subsidiaries’ non-controlling interests
Pembagian dividen kas 22 - - - - (1.171.878.052.750) - - - (1.171.878.052.750) (18.739.213.100) (1.190.617.265.850) Distribution of cash dividends
Total laba komprehensif tahun 2018 - - - - 2.457.129.032.271 10.588.832.653 5.488.147.308 37.444.867.020 2.510.650.879.252 42.056.066.372 2.552.706.945.624 Total comprehensive income for 2018
Saldo pada tanggal 31 Desember 2018 468.751.221.100 (34.118.673.814) 46.967.626.117 201.390.130.325 13.871.718.983.242 71.460.322.752 42.056.395.763 (44.768.029.424) 14.623.457.976.061 671.136.820.293 15.294.594.796.354 Balance as of December 31, 2018
Saldo laba yang telah ditentukan penggunaannya untuk cadangan umum 2z,22 - - - 24.571.290.323 (24.571.290.323) - - - - - - Appropriation of retained earnings for general reserves
Selisih kurs atas penjabaran laporan keuangan 2c - - - - - - - - - (247.812.600) (247.812.600) Differences arising from foreign currency translation
Setoran modal dari kepentingan non-pengendali entitas anak 2c - - - - - - - - - 183.708.000.000 183.708.000.000 Additional capital from subsidiaries’ non-controlling interests
Pembagian dividen kas 22 - - - - (1.218.753.174.860 ) - - - (1.218.753.174.860) (34.111.005.919) (1.252.864.180.779) Distribution of cash dividends
Pencairan aset keuangan tersedia untuk dijual 2v,7 - - - - - - 269.966 - 269.966 - 269.966 Withdrawal of available-for-sale financial assets
Akuisisi kepentingan non-pengendali 2c,24 - - 6.171.237.158 - - - - - 6.171.237.158 (41.019.237.158 ) (34.848.000.000) Acquisition of non-controlling interests
Pelepasan sebagian kepemilikan pada entitas anak yang tidak 2c,24
mengakibatkan hilangnya pengendalian - - (206.027.219 ) - - - - - (206.027.219) 2.203.027.219 1.997.000.000 Partial disposal of interest in a subsidiary without loss of control
Total laba komprehensif tahun 2019 - - - - 2.506.764.572.075 (13.635.660.991) 13.949.492.530 (24.622.293.726 ) 2.482.456.109.888 30.786.293.202 2.513.242.403.090 Total comprehensive income for 2019
Saldo pada tanggal 31 Desember 2019 468.751.221.100 (34.118.673.814) 52.932.836.056 225.961.420.648 15.135.159.090.134 57.824.661.761 56.006.158.259 (69.390.323.150 ) 15.893.126.390.994 812.456.085.037 16.705.582.476.031 Balance as of December 31, 2019
Catatan atas laporan keuangan konsolidasian terlampir merupakan bagian integral The accompanying notes to the consolidated financial statements form an integral part of
dari laporan keuangan konsolidasian. these consolidated financial statements.
6
The original consolidated financial statements included herein are in
the Indonesian language.
PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN ARUS KAS KONSOLIDASIAN CONSOLIDATED STATEMENT OF CASH FLOWS
Untuk Tahun yang Berakhir pada Tanggal For the Year Ended December 31, 2019
31 Desember 2019 (Expressed in Rupiah, unless otherwise stated)
(Disajikan dalam Rupiah, kecuali dinyatakan lain)
Kas yang dihasilkan dari operasi 9.376.719.590.728 9.300.270.337.208 Cash generated from operations
Penerimaan tagihan restitusi pajak 20.914.275.240 2.959.085.712 Receipts of claims for tax refund
Pembayaran pajak penghasilan (839.509.478.376) (838.106.813.718) Payments for income taxes
Pembayaran untuk beban operasi Payments for other operating
lainnya, neto (6.055.155.565.201) (5.694.346.659.743) expenses, net
Catatan atas laporan keuangan konsolidasian terlampir The accompanying notes to the consolidated financial
merupakan bagian integral dari laporan keuangan statements form an integral part of these consolidated financial
konsolidasian. statements.
7
The original consolidated financial statements included herein are in
the Indonesian language.
PT KALBE FARMA Tbk. DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk. AND ITS SUBSIDIARIES
LAPORAN ARUS KAS KONSOLIDASIAN (lanjutan) CONSOLIDATED STATEMENT OF CASH FLOWS
Untuk Tahun yang Berakhir pada Tanggal (continued)
31 Desember 2019 For the Year Ended December 31, 2019
(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
Catatan/
2019 Notes 2018
Catatan atas laporan keuangan konsolidasian terlampir The accompanying notes to the consolidated financial
merupakan bagian integral dari laporan keuangan statement form an integral part of these consolidated financial
konsolidasian. statements.